AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (September 2021) - Marsilio, I.; Maniero, D.; Lorenzon, G.; Rigo, A.; Cardin, R.; Facchin, S.; Barberio, B.; D'Incà, R.; Zingone, F.; Bahur, B.; Bray, K.; Savarino, E.